How it works
The patient is first examined for DNA from the tumor tissue (or pre-operative blood sample), and the DNA mutations found are subsequently repeatedly screened in the patient's plasma.
If a DNA mutation is detected in the blood, the patient is immediately recommended for further testing to confirm the diagnosis. Subsequent treatment is already done within the standard cancer care system.
How oncoMonitor™ test works step by step:
1. The patient will receive initial information from their attending physician or on our website or contact us via the online form. Upon receipt, we will evaluate it and contact the patient immediately about the appropriateness of using the oncoMonitor™ test.
2. The attending physician will provide detailed information to the patient and explain the whole issue. The availability of tumor tissue samples is determined, pricing is proposed, and the patient signs the approval of the examination.
3. Blood samples are collected from the patient and the blood plasma is subsequently examined for the presence of DNA mutations.
4. The test results are evaluated and sent to the attending physician who will decide about further steps. The test results are always available within 14 days of the patient's blood collection.
5. The design of regular intervals for further blood sampling is created for the best use of the obtained results. Usually, the following blood collections are at 3-month time intervals, so a total of 4 blood samples are examined for one year.
Reimbursement for oncoMonitor™
OncoMonitor™ is currently not covered by health insurance companies in the Czech Republic.
It is a completely unique and above-standard service, the patient is a self-payer.